abstract |
The present invention relates to patients who have been diagnosed with or at high risk of developing an immunoinflammatory disorder by administering to a patient a tetrasubstituted pyrimidopyrimidine, alone or in combination with one or more additional agents. Features a method for treating. The invention also features a composition comprising a tetrasubstituted pyrimidopyrimidine in combination with one or more additional agents. |